Beyond The Printed Page

  1. Pfizer’s Head Of R&D On The Importance Of Being Hyper Focused

    Pfizer’s top scientist, Mikael Dolsten, M.D., Ph.D., talks about being hyper focused during company’s R&D turnaround amongst CEO turnover, company integrations and M&A.

  2. How Tony Robbins Became An Investor In Celularity

    Robert Hariri, M.D., Ph.D., discusses how he became friends with life coach Tony Robbins, and why Robbins decided to invest in his company.

  3. Support For Women-Led Early-Stage Life Sciences Companies

    A preview of an October 2109 issue article that discusses the results of the 2018 MassNextGen initiative that provides funding and coaching support to early-stage life sciences companies started by females.

  4. Robert Hariri’s Accidental Entry Into Filmmaking

    Robert Hariri, M.D., Ph.D., CEO of Celularity Therapeutics, shares how a biopharmaceutical industry CEO has come to know Hollywood celebrities.

  5. How LifeBankUSA Became A Life-Changing Investment

    Robert Hariri, M.D., Ph.D., CEO of Celularity, shares a story of an investor’s life being altered dramatically by an investment in one of his companies.

  6. Why Mutually Beneficial Partnerships Can Be Hard To Find For Startups

    Bassil Dahiyat, Ph.D., president and CEO of Xencor, shares his perspective on why full-time equivalent (FTE) partnering deals are money losers.

  7. 3 Valuable Lessons Learned By A First-Time Entrepreneur

    Bassil Dahiyat, Ph.D., president and CEO of Xencor, a publicly traded biotech he founded right out of graduate school, shares three formative experiences gained as a first-time entrepreneur.

  8. Why Orchard Therapeutics Mark Rothera Is A Rare Disease Champion

    The career path of Orchard Therapeutics’ CEO Mark Rothera provides insight into how the executive came to be a champion of rare disease drug development.

  9. How Mark Rothera Came To His Dream Job

    Mark Rothera spent the majority of his career working for U.S.-based biopharmas. So, when he had the opportunity to work in his home country and preferred therapeutic area, he pursued it relentlessly.

  10. 6 Things You Might Not Know About Richard Pops, CEO Of Alkermes

    You might know Richard Pops is one of the longest tenured CEOs in biopharma, but here are six things perhaps you didn’t know about the chairman of Alkermes.